Welcome to LookChem.com Sign In|Join Free

CAS

  • or

848492-86-4

Post Buying Request

848492-86-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

848492-86-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 848492-86-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,4,9 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 848492-86:
(8*8)+(7*4)+(6*8)+(5*4)+(4*9)+(3*2)+(2*8)+(1*6)=224
224 % 10 = 4
So 848492-86-4 is a valid CAS Registry Number.

848492-86-4Relevant articles and documents

PESTICIDAL COMPOSITIONS AND METHODS

-

Page/Page column 103, (2020/08/22)

This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules, and processes of using such molecules against such pests. These molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses molecules having the structure of Formula A.

Palladium(0)-catalyzed intramolecular decarboxylative allylation of ortho nitrobenzoic esters

Hossian, Asik,Singha, Shantanu,Jana, Ranjan

, p. 3934 - 3937 (2014/08/18)

A Pd/Ag bimetallic system has been developed for the decarboxylative allylation of ortho-nitrobenzoic esters in an intramolecular fashion. In contrast to the typical sp2-sp3 cross-coupling approach which requires air and moisture sensitive preformed organometallic reagents, we provide an alternative route to the synthesis of ortho-allyl nitroarenes from the corresponding ortho-nitrobenzoic acid derivatives. The reaction proceeds through a mechanistically distinct decarboxylative metalation pathway. A cooperative reactivity of palladium and silver is crucial for the reaction outcome.

QUINOXALINE COMPOUNDS AND USE THEREOF

-

Page/Page column 81-82, (2008/12/08)

The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 848492-86-4